Skip to main content Skip to main navigation menu Skip to site footer
Page Header Logo
  • Home
  • About
    • About the Journal
    • Aims & scope
    • Editorial Board
    • Contact Information
  • Current
  • Archives
  • Indexing & Abstracting
  • For Authors
    • Author Guidelines
    • Peer Review Policy
    • Ethical Consideration
    • Publication Ethics and Malpractice Statement
    • Submissions
Search
  • Register
  • Login
  1. Home /
  2. Search

Advanced filters
Nephrotic syndrome as the first manifestation of Acute Myelogenous leukemia
Mohammadali Mashhadi
High Dose Methotrexat Liver Toxicity
Mohammad ali Mashhadi, Mohammd Mahammadi, Alireza Bakhshipour, Mahmoudali Keikhaei, Mahnaz Sandoughi, Zahra Heidari, Hooshang Sanadgol, Amin Mashhadi
IEV (Ifosfamide, Epirubicin, VP16) Regimen as Salvage Therapy for Early Relapsed/Refractory non-Hodgkin/Hodgkin Lymphoma
Mohammad ali Mashhadi, Hossein Rahimi, Behrooz Najafi, Adnan Khosravi
Gastric Cancer in South East of Iran
Mohammadali Mashhadi, K Nazem, MJ Abdollahinejad
Neuropsychiatric Toxicity of Ifosfamide in Patients Admitted for Chemotherapy
Mohammadali Mashhadi, Alireza Khosravi
Association of High Serum Leptin Level with Papillary Thyroid Carcinoma: A Case-Control Study
Roya Refahi, Zahra Heidari, Mohammadali Mashhadi
Published: 2023-07-20
1 - 6 of 6 items


2025 CiteScore: 1.0

pISSN: 2008-3009
eISSN: 2008-2207

 

Editor-in-Chief:
Ardeshir Ghavamzadeh, MD.

Chairman:
Ghasem Janbabaei

 

This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE).

1.0
2025CiteScore
 
 
30th percentile
Powered by  Scopus

 

SCImago Journal & Country Rank

Make a Submission
Information
  • Publication Fee
  • For Readers
  • For Authors
  • For Librarians
International Journal of Hematology-Oncology and Stem Cell Research (Quarterly), pISSN: 2008-3009, eISSN: 2008-2207
Tehran University of Medical Sciences, Tehran, Iran.

All the work in this journal are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source.